ARCHIVES

IOM, NCI Clash Over Proposed Change in Tabulating Minority Research

This article is from The Cancer Letter archive.

Vol. 25 No. 03 | January 22, 1999

Download PDF Visit The Full Archive

Related Articles

Centocor Withdraws Yondelis After FDA Calls for New Study

April 29, 2011

NSABP Breast Cancer Prevention Trial Reports Final Results On Tamoxifen

November 25, 2005

FDA’s Young Still Not Satisfied With Distribution Plan

September 9, 1977

DCPC Bard Approves $10 Million In Concepts

October 2, 1987

Talbot, Schein Ask Weickar for 41.3 Billion for NCI

May 6, 1983

Study: End-of-Life Chemotherapy Leads to More Deaths in Hospital

March 28, 2014